Morning Market Losers

By: via Benzinga
Sarepta Therapeutics (NASDAQ: SRPT) fell 25.03% to $19.41 after the company offered long-term outcomes through 144 weeks from Phase IIb ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.